Overview
Treatment Optimization in Autoimmune Neuromuscular Diseases
CPE/CE is no longer available for this activity.
This webinar features a roundtable discussion and a question and answer session highlighting the diagnosis, electrophysiological testing, and treatment of these diseases with IVIG and/or new formulations of SCIG in an effort to provide individualized treatments and minimize adverse events.
Patient outcomes can be significantly enhanced with early identification and differential diagnosis of autoimmune neuromuscular disorders, namely CIPD, GBS, MG, and MMN.
Patient outcomes can be significantly enhanced with early identification and differential diagnosis of autoimmune neuromuscular disorders, namely CIPD, GBS, MG, and MMN.
This educational activity is designed for neurologists, physiatrists, pharmacists and other healthcare professionals who practice in the hospital setting with an interest in the management of neuromuscular diseases.
Patient outcomes can be significantly enhanced with early identification and differential diagnosis of autoimmune neuromuscular disorders, namely CIPD, GBS, MG, and MMN. This roundtable will feature a faculty-led discussion and a question and answer session highlighting the diagnosis, electrophysiological testing, and treatment of these diseases with IVIG and/or new formulations of SCIG in an effort to provide individualized treatments and minimize adverse events.
Autoimmune neuromuscular disorders are considered to be a heterogeneous grouping of a number of diseases that may be differentiated based on the timing of symptom presentation, pattern of presentation/clinical phenotype (ie, symmetrical vs asymmetrical, distal vs proximal, sensory vs motor), EMG pattern, and laboratory chemistries. Differential diagnosis may be challenging as oftentimes there are only slight nuances that differentiate one disease from another. Clinicians will be introduced to consensus statements and advances in therapy, as well as new treatment modalities (ie, dosage and timing) in an effort to enhance recognition, diagnosis, and appropriate treatment selection earlier in the disease course so as to result in improved patient outcomes.
Upon completion of this activity, participants should be better able to:
• Discuss disease heterogeneity and potential clinical presentations for patients with autoimmune neuromuscular disorders
• Analyze and implement scientific evidence supporting the use of clinical, electrophysiological, and ancillary parameters in the diagnosis of autoimmune neuromuscular diseases
• Select appropriate therapies and recognize potential treatment failures on the basis of patient history and available clinical evidence
• Evaluate and monitor dosage and timing of treatment for autoimmune neuromuscular diseases based on clinical guidelines and expert opinion
• Assess current and changing standards of care for long-term clinical management of autoimmune neuromuscular diseases
• Discuss disease heterogeneity and potential clinical presentations for patients with autoimmune neuromuscular disorders
• Analyze and implement scientific evidence supporting the use of clinical, electrophysiological, and ancillary parameters in the diagnosis of autoimmune neuromuscular diseases
• Select appropriate therapies and recognize potential treatment failures on the basis of patient history and available clinical evidence
• Evaluate and monitor dosage and timing of treatment for autoimmune neuromuscular diseases based on clinical guidelines and expert opinion
• Assess current and changing standards of care for long-term clinical management of autoimmune neuromuscular diseases
This activity was planned and implemented by Indiana University School of Medicine, the Academy for Continued Healthcare Learning (ACHL), and VHA.
This activity is supported by educational grants from Baxalta US Inc. and Grifols.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 4.0 or higher and Firefox 3.0 or higher
4. Adobe Flash Player 8.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 4.0 or higher and Firefox 3.0 or higher
4. Adobe Flash Player 8.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Gil I. Wolfe, MD (Chair)
Irvin & Rosemary Smith Professor and Chairman
Department of Neurology
University of Buffalo, State University of New York
Irvin & Rosemary Smith Professor and Chairman
Department of Neurology
University of Buffalo, State University of New York
Eric Ensrud, MD
Director, Neuromuscular Center, Boston VA Healthcare System
Director, Neuromuscular Rehab Clinic, Brigham and Women's Hospital
Carol Lee Koski, MD
Medical Director, GBS/CIDP Foundation International
Professor of Neurology (retired), University of Maryland School of Medicine
The following faculty financial relationships have been provided:
Gil I. Wolfe, MD
Consulting: Baxter Healthcare Corporation, Grifols
Research: Alexion
Speaking: Grifols
Gil I. Wolfe, MD
Consulting: Baxter Healthcare Corporation, Grifols
Research: Alexion
Speaking: Grifols
Eric Ensrud, MD
Consulting: Convergence Medical Devices
Honorarium: Osler Institute
Carol Lee Koski, MD
Honorarium: Baxter Healthcare Corporation, CSL Behring, Grifols
Disclosure of Unlabeled Use: None
ACHL and Indiana University School of Medicine staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
This activity will take approximately 60 minutes to complete. This broadcast will consist of lectures that include discussion of case studies with collateral slides and an interactive question and answer session.
To receive credit after viewing the online webcast, complete the post-test and evaluation. To receive credit, 80% must be achieved on the post-test.
A certificate will be immediately available and pharmacist credit will be uploaded to CPE Monitor within 60 days of completion. Partial credit may not be awarded for CPE credit; participation in the complete activity is required to receive credit There is no fee to participate in the activity or for the generation of the certificate.
Physicians
Accreditation Statement
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Pharmacists
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Accreditation Statement
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Indiana University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.
Pharmacists
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity has been approved for a maximum of 1.0 contact hour.
Activity Type: Application
ACPE Universal Activity Number (UAN): 0396-0000-14-053-H01-P